查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
到 2030 年自動並行勝胜肽合成儀的市場預測：按類型、應用和區域分類的全球分析
市場調查報告書
商品編碼
1383341

到 2030 年自動並行勝胜肽合成儀的市場預測：按類型、應用和區域分類的全球分析

Automatic Parallel Peptide Synthesiser Market Forecasts to 2030 - Global Analysis By Type (Fully-Automatic and Semi-Automatic), Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球自動化胜肽合成儀市場規模為 6.01 億美元，預計在預測期內年複合成長率為 9.4%，到 2030 年將達到 11.27 億美元。

自動並行勝胜肽合成儀是生物學和化學領域用於自動合成勝胜肽的專用工具。蛋白質主要由胜肽組成，胜肽是胺基酸的短鏈。胜肽合成儀是科學家和研究人員用來產生精確胺基酸序列的工具，用於藥物開發、蛋白質研究、生化研究等。某些合成器還可能具有整合的勝胜肽精製和分析功能，例如質譜和高效液相層析(HPLC)。

對基於胜肽的療法的需求不斷成長

由胜肽和蛋白質製成的藥物稱為“胜肽療法”，包括胜肽藥物和生技藥品。胜肽藥物由於具有比傳統小分子藥物低毒性和更高特異性的特殊優勢，在生物技術和製藥領域越來越受歡迎。高標靶特異性是胜肽療法的一個眾所周知的特徵，因此它們可以被設計為作用於特定的蛋白質、細胞或受體。此外，隨著對更個體化和加護治療的需求的增加，越來越需要由自動並行勝胜肽合成儀生產的客製化設計的胜肽。

缺乏技術純熟勞工

對高素質勞動力的需求可能會讓新興企業、小型研究機構和資金有限的公司難以起步。此外，還需要花費大量的時間和金錢來培訓人力資源來操作自動合成儀並進行胜肽合成。當關鍵人員離開或無法使用時，嚴重依賴技術純熟勞工的企業可能會遇到困難，而依賴少數人可能會帶來危險或擾亂業務，市場成長將受到阻礙。

個人化醫療日益受到關注

個人化醫療的目標是根據患者獨特的遺傳和分子特徵進行治療。有可能創造出專門特異性與患者疾病相關的基因突變和生物標記並與之相互作用的胜肽。透過自動平行胜肽合成儀可以快速有效地合成患者特異性勝胜肽。透過客製化勝胜肽，我們可以針對每個人疾病的遺傳和生化特徵做出反應。基因組學和 DNA 測序新興市場的開拓使得檢測與疾病相關的特定遺傳變異和突變成為可能，從而使自動胜肽能夠產生精確靶向這些遺傳標記的胜肽。市場。

技術過時

較舊的合成器可能不具有與較新版本相同的特性、功能或效率。由於消費者被最新的創新所吸引並且不再投資過時的機器，老式合成器的製造商可能面臨較少的競爭。新一代合成器配件和軟體可能無法與早期型號配合使用，這限制了您利用最新功能並將您的儀器與其他實驗室系統和設備連接的能力。

COVID-19 的影響

這場流行病加速了對抗病毒胜肽的尋找，這對於創造治療方法和疫苗接種至關重要。因此，需要胜肽合成儀來生產抗病毒勝胜肽。 COVID-19 疫苗的快速發展推動了對這種胜肽合成儀的需求，其中一些疫苗的配方中含有胜肽。對遠端工作和社會隔離的需求促使組織探索設備的自動化和遠端監控，特別是胜肽合成器。此外，政府加大了對 COVID-19 相關的疫苗生產和研究的支持，使得購買胜肽合成器成為可能。

預計全自動細分市場在預測期內將是最大的

全自動部分預計將有良好的成長，因為這些胜肽合成步驟可以在全自動合成儀上同時處理，從而實現高通量勝胜肽生產。這些合成儀確保了胜肽的合成，因為可以精確控制溫度、時間和試劑濃度等反應參數。另外，高效液相層析（HPLC）和質譜是某些全自動合成儀提供的兩種整合精製和分析能力，可以快速生產純勝胜肽並擴大市場。我會支持你。

醫療級預計在預測期內年複合成長率最高

醫療級自動平行胜肽合成儀是為滿足醫療和醫療產業的特定要求而設計的專用工具，因此，醫療領域預計在預測期內將呈現最高的年複合成長率。這些合成器的主要應用是自動合成醫學重要的胜肽，例如用於藥物開發、診斷測試和治療應用的胜肽。在醫學研究中，基於胜肽的疫苗接種用於誘導免疫反應。這些疫苗的胜肽成分必須使用自動合成儀自動合成。

比最大的地區

由於生物技術、製藥和生命科學領域的研發活動大幅增加，預計亞太地區在預測期內將佔據最大的市場佔有率。這些研究很大程度上依賴胜肽合成，從而推動了對自動化平行勝胜肽合成器的需求。由於基因組學、蛋白質組學和客製化醫學等生物技術的進步，對胜肽合成器的需求越來越大，這些進步被用於生物標記識別、診斷分析的創建和個體化胜肽治療。

複合年複合成長率最高的地區：

由於藥品研發集中在歐洲，預計歐洲在預測期內的年複合成長率最高。該地區積極參與多項藥物研究和藥物研發發現計劃，包括生技藥品和胜肽藥物的合成。許多提供客製化勝胜肽合成服務的公司都位於歐洲。此外，其他地區的製藥公司與歐洲研究機構之間的合作日益增多，也增加了對先進勝胜肽合成設備的需求。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計/預測/年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球自動並行勝胜肽合成器市場：按類型

  • 介紹
  • 全自動
  • 半自動

第6章 全球自動平行勝胜肽合成器市場：按應用

  • 介紹
  • 醫療保健
  • 實驗室
  • 其他用途

第7章 全球自動並行勝胜肽合成器市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第8章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第9章 公司簡介

  • Activotec
  • MultiSynTech GmbH
  • CEM GmbH
  • Biotage
  • AAPPTEC
  • PolyPeptide Group
  • CreoSalus
  • AnproTech Inc.
  • Telegenixx
  • Almac Group
  • Next Pharma Inc.
Product Code: SMRC24191

According to Stratistics MRC, the Global Automatic Parallel Peptide Synthesiser Market is accounted for $601 million in 2023 and is expected to reach $1127 million by 2030 growing at a CAGR of 9.4% during the forecast period. A specialized tool used in biology and chemistry for the automated synthesis of peptides is an automatic parallel peptide synthesizer. Proteins are mostly made up of peptides, which are short chains of amino acids. Peptide synthesizers are tools used by scientists and researchers to manufacture precise amino acid sequences for use in medication development, protein studies, and biochemical research, among other uses. Certain synthesizers may be equipped with integrated peptide purification and analysis functions, such as mass spectrometry or high-performance liquid chromatography (HPLC).

Market Dynamics:

Driver:

Rising demand for peptide-based therapeutics

Pharmaceuticals made from peptides or proteins are referred to as "peptide-based therapeutics," which also includes peptide medications and biologics. They are becoming more and more well-known in the biotechnology and pharmaceutical sectors because of their special benefits, which include reduced toxicity and higher specificity than conventional small molecule medications. High target specificity is a well-known characteristic of peptide-based therapies thus they may be engineered to engage with particular proteins, cells, or receptors. Moreover, custom-designed peptides produced by automated parallel peptide synthesizers are becoming more and more necessary as the need for more individualized and focused therapies rises.

Restraint:

Lack of availability of a skilled workforce

The requirement for a highly qualified labor may make it difficult for startups, smaller research institutions, and enterprises with tight funds to get started. These organizations can find it difficult to draw in and keep people with the right kind of experience and it can take a lot of time and money to train people to operate automated synthesizers and perform peptide synthesis. Businesses that depend significantly on skilled workers may experience difficulties if important individuals depart or are unavailable where reliance on a small number of people might result in dangers and interruptions to operations thereby hindering the growth of the market.

Opportunity:

Growing focus on personalized medicine

Treating patients according to their unique genetic and molecular profiles is the goal of personalized medicine. It is possible to create peptides that specifically target and interact with genetic variants or biomarkers linked to a patient's illness. Rapid and effective synthesis of peptides tailored to a patient is made possible by automatic parallel peptide synthesizers. The distinct genetic and biochemical features of each person's illness can be catered for by customizing these peptides. It is now feasible to detect certain genetic variants and mutations linked to illnesses because to developments in genomics and DNA sequencing thus peptides that precisely target these genetic markers can be created using automatic peptide synthesizers which propels the market growth.

Threat:

Technological obsolescence

Older synthesizers might not have the same features, functionalities, or efficiency as more recent versions. Manufacturers of older synthesizers may face less competition as a result of consumers who are drawn to the newest innovations and may be discouraged from investing in antiquated machinery. It's possible that accessories and software from more recent generations of synthesizers won't work with earlier models, which would restrict capacity to utilize the newest features and link your equipment with other lab systems and instruments.

COVID-19 Impact

Research into antiviral peptides, which are essential for creating cures and vaccinations, was expedited by the epidemic. The need for peptide synthesizers to produce antiviral peptides arose as a result thus the need for peptide synthesis equipment was fueled by the COVID-19 vaccines' quick development, several of which contain peptides in their formulations. Organizations are investigating automation and remote monitoring of equipment, particularly peptide synthesizers, due to the necessity for distant work and social isolation. Moreover, increasing government support for vaccine production and research connected to COVID-19 made it possible to purchase peptide synthesizers.

The fully-automatic segment is expected to be the largest during the forecast period

The fully-automatic segment is estimated to have a lucrative growth, as these peptide synthesis processes may be handled concurrently by fully-automatic synthesizers, allowing for high-throughput peptide manufacturing. Peptide synthesis is guaranteed by these synthesizers because they provide exact control over reaction parameters like temperature, duration, and reagent concentrations. Furthermore high-performance liquid chromatography (HPLC) and mass spectrometry are two integrated purification and analysis features that certain fully-automatic synthesizers offer, making it possible to produce pure peptides quickly thus encouraging in the market expansion.

The medical segment is expected to have the highest CAGR during the forecast period

The medical segment is anticipated to witness the highest CAGR growth during the forecast period, because the medical-grade automatic parallel peptide synthesizers are specialist tools made to meet the specific requirements of the healthcare and medical industries. The automated synthesis of peptides of medical significance, such as those employed in medication development, diagnostic tests, and therapeutic applications, is the main usage for these synthesizers. Medical research use vaccinations based on peptides to elicit immune responses. The peptide components of these vaccines must be synthesized automatically using automatic synthesizers.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the biotechnology, pharmaceutical, and life sciences sectors which are seeing a significant increase in research and development activity in the Asia-Pacific area. These studies heavily rely on peptide synthesis, which fuels the need for automated parallel peptide synthesizers. Peptide synthesizers are becoming more and more in demand because to advancements in biotechnology such as genomics, proteomics, and customized medicine, these advancements are being used to biomarker identification, the creation of diagnostic assays, and individualized peptide therapeutics.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to Research & development for pharmaceuticals which are concentrated in Europe. The area is actively involved in several drug research and discovery initiatives, many of which entail the synthesis of biologics and peptide-based medications. Numerous businesses offering bespoke peptide synthesis services are based in Europe. Additionally, due to the increasing number of collaborations between pharmaceutical corporations from other areas and European research institutes is driving up the demand for sophisticated equipment for peptide synthesis.

Key players in the market

Some of the key players profiled in the Automatic Parallel Peptide Synthesiser Market include: Activotec, MultiSynTech GmbH, CEM GmbH, Biotage, AAPPTEC, PolyPeptide Group, CreoSalus, AnproTech Inc., Telegenixx, Almac Group and Next Pharma Inc.

Key Developments:

In June 2023, Biotage completes the acquisition of Astrea Bioseparations and resolves on a share issue to the Sellers as part of the acquisition. The acquisition also includes the shares held by certain minority investors in the Astrea group.

In March 2021, Activotec collaborated with Coronex to develop a game-changing platform for lateral flow (LF) tests that could be vital in the fight against COVID-19. This proprietary platform technology has been used to develop highly optimised LF tests for SARS-Cov-2 antibodies.

In February 2021, MultiSynTech GmbH and Biotage AB join forces and enter the peptide synthesis business. The agreements with MultiSynTech will grant Biotage distribution rights for all current MultiSynTech peptide synthesis systems.

Types Covered:

  • Fully-Automatic
  • Semi-Automatic

Applications Covered:

  • Medical
  • Laboratory
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Automatic Parallel Peptide Synthesiser Market, By Type

  • 5.1 Introduction
  • 5.2 Fully-Automatic
  • 5.3 Semi-Automatic

6 Global Automatic Parallel Peptide Synthesiser Market, By Application

  • 6.1 Introduction
  • 6.2 Medical
  • 6.3 Laboratory
  • 6.4 Other Applications

7 Global Automatic Parallel Peptide Synthesiser Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Activotec
  • 9.2 MultiSynTech GmbH
  • 9.3 CEM GmbH
  • 9.4 Biotage
  • 9.5 AAPPTEC
  • 9.6 PolyPeptide Group
  • 9.7 CreoSalus
  • 9.8 AnproTech Inc.
  • 9.9 Telegenixx
  • 9.10 Almac Group
  • 9.11 Next Pharma Inc.

List of Tables

  • Table 1 Global Automatic Parallel Peptide Synthesiser Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Automatic Parallel Peptide Synthesiser Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Automatic Parallel Peptide Synthesiser Market Outlook, By Fully-Automatic (2021-2030) ($MN)
  • Table 4 Global Automatic Parallel Peptide Synthesiser Market Outlook, By Semi-Automatic (2021-2030) ($MN)
  • Table 5 Global Automatic Parallel Peptide Synthesiser Market Outlook, By Application (2021-2030) ($MN)
  • Table 6 Global Automatic Parallel Peptide Synthesiser Market Outlook, By Medical (2021-2030) ($MN)
  • Table 7 Global Automatic Parallel Peptide Synthesiser Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 8 Global Automatic Parallel Peptide Synthesiser Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 9 North America Automatic Parallel Peptide Synthesiser Market Outlook, By Country (2021-2030) ($MN)
  • Table 10 North America Automatic Parallel Peptide Synthesiser Market Outlook, By Type (2021-2030) ($MN)
  • Table 11 North America Automatic Parallel Peptide Synthesiser Market Outlook, By Fully-Automatic (2021-2030) ($MN)
  • Table 12 North America Automatic Parallel Peptide Synthesiser Market Outlook, By Semi-Automatic (2021-2030) ($MN)
  • Table 13 North America Automatic Parallel Peptide Synthesiser Market Outlook, By Application (2021-2030) ($MN)
  • Table 14 North America Automatic Parallel Peptide Synthesiser Market Outlook, By Medical (2021-2030) ($MN)
  • Table 15 North America Automatic Parallel Peptide Synthesiser Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 16 North America Automatic Parallel Peptide Synthesiser Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 17 Europe Automatic Parallel Peptide Synthesiser Market Outlook, By Country (2021-2030) ($MN)
  • Table 18 Europe Automatic Parallel Peptide Synthesiser Market Outlook, By Type (2021-2030) ($MN)
  • Table 19 Europe Automatic Parallel Peptide Synthesiser Market Outlook, By Fully-Automatic (2021-2030) ($MN)
  • Table 20 Europe Automatic Parallel Peptide Synthesiser Market Outlook, By Semi-Automatic (2021-2030) ($MN)
  • Table 21 Europe Automatic Parallel Peptide Synthesiser Market Outlook, By Application (2021-2030) ($MN)
  • Table 22 Europe Automatic Parallel Peptide Synthesiser Market Outlook, By Medical (2021-2030) ($MN)
  • Table 23 Europe Automatic Parallel Peptide Synthesiser Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 24 Europe Automatic Parallel Peptide Synthesiser Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 25 Asia Pacific Automatic Parallel Peptide Synthesiser Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 Asia Pacific Automatic Parallel Peptide Synthesiser Market Outlook, By Type (2021-2030) ($MN)
  • Table 27 Asia Pacific Automatic Parallel Peptide Synthesiser Market Outlook, By Fully-Automatic (2021-2030) ($MN)
  • Table 28 Asia Pacific Automatic Parallel Peptide Synthesiser Market Outlook, By Semi-Automatic (2021-2030) ($MN)
  • Table 29 Asia Pacific Automatic Parallel Peptide Synthesiser Market Outlook, By Application (2021-2030) ($MN)
  • Table 30 Asia Pacific Automatic Parallel Peptide Synthesiser Market Outlook, By Medical (2021-2030) ($MN)
  • Table 31 Asia Pacific Automatic Parallel Peptide Synthesiser Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 32 Asia Pacific Automatic Parallel Peptide Synthesiser Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 33 South America Automatic Parallel Peptide Synthesiser Market Outlook, By Country (2021-2030) ($MN)
  • Table 34 South America Automatic Parallel Peptide Synthesiser Market Outlook, By Type (2021-2030) ($MN)
  • Table 35 South America Automatic Parallel Peptide Synthesiser Market Outlook, By Fully-Automatic (2021-2030) ($MN)
  • Table 36 South America Automatic Parallel Peptide Synthesiser Market Outlook, By Semi-Automatic (2021-2030) ($MN)
  • Table 37 South America Automatic Parallel Peptide Synthesiser Market Outlook, By Application (2021-2030) ($MN)
  • Table 38 South America Automatic Parallel Peptide Synthesiser Market Outlook, By Medical (2021-2030) ($MN)
  • Table 39 South America Automatic Parallel Peptide Synthesiser Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 40 South America Automatic Parallel Peptide Synthesiser Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 41 Middle East & Africa Automatic Parallel Peptide Synthesiser Market Outlook, By Country (2021-2030) ($MN)
  • Table 42 Middle East & Africa Automatic Parallel Peptide Synthesiser Market Outlook, By Type (2021-2030) ($MN)
  • Table 43 Middle East & Africa Automatic Parallel Peptide Synthesiser Market Outlook, By Fully-Automatic (2021-2030) ($MN)
  • Table 44 Middle East & Africa Automatic Parallel Peptide Synthesiser Market Outlook, By Semi-Automatic (2021-2030) ($MN)
  • Table 45 Middle East & Africa Automatic Parallel Peptide Synthesiser Market Outlook, By Application (2021-2030) ($MN)
  • Table 46 Middle East & Africa Automatic Parallel Peptide Synthesiser Market Outlook, By Medical (2021-2030) ($MN)
  • Table 47 Middle East & Africa Automatic Parallel Peptide Synthesiser Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 48 Middle East & Africa Automatic Parallel Peptide Synthesiser Market Outlook, By Other Applications (2021-2030) ($MN)